Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Investor Presentation

29 Oct 2021 07:00

RNS Number : 6257Q
Versarien PLC
29 October 2021
 

29 October 2021

Versarien Plc

("Versarien" or the "Company")

Investor Presentation

 

Versarien (AIM: VRS), the advanced materials engineering group, is pleased to announce that the executive management of the Company will hold a live investor presentation via the Investor Meet Company platform on 10 November 2021 at 5:00pm GMT.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9:00am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Versarien via:

https://www.investormeetcompany.com/versarien-plc/register-investor

Investors who already follow Versarien on the Investor Meet Company platform will automatically be invited.

 

Enquiries:

 

Versarien

Neill Ricketts, CEO

Chris Leigh, CFO

+44 (0)1594 887204

SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

Matthew Johnson, Ewan Leggat, Adam Cowl

 

+44 (0)20 3470 0470

Berenberg (Joint Broker)

Mark Whitmore, Simon Cardron

+44 (0)20 3207 7800

Yellow Jersey (Investor Relations) 

Charles Goodwin

Henry Wilkinson

 

Versarien@yellowjerseypr.com

+44 (0)20 3004 9512

 

 

 Notes to Editors:

 

About Versarien

 

Versarien Plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries.

For further information please see: http://www.versarien.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFFSIELTFIL
Date   Source Headline
4th Apr 20178:00 amRNSHolding(s) in Company
21st Mar 20177:00 amRNSCambridge Graphene Update
15th Mar 20179:43 amRNSHolding(s) in Company
9th Mar 20171:00 pmRNSHolding(s) in Company
6th Mar 20177:00 amRNSSuccessful Fundraising of £1.5 million
3rd Mar 20174:38 pmRNSFundraising of approximately £1 million
16th Feb 20177:00 amRNSNanene Distribution Agreement
8th Feb 20177:00 amRNSLaunch of Nanene
30th Jan 201710:04 amRNSHolding(s) in Company
19th Jan 20171:21 pmRNSAcquisition and Trading Update
19th Dec 20167:00 amRNSFurther Graphene Enhanced PAEK Plastics Agreement
14th Dec 201610:45 amRNSHolding(s) in Company
14th Dec 20167:00 amRNSGraphene enhanced PAEK Thermoplastics Agreement
29th Nov 20167:01 amRNSInterim Results
29th Nov 20167:00 amRNSSignificant Graphene Order
23rd Nov 20167:00 amRNSNotice of Results
9th Nov 201610:00 amRNSInvestor site visit presentations
31st Oct 20169:15 amRNSDebt for Equity Swap with UoM
27th Oct 20167:00 amRNSNew Healthcare Graphene Project
18th Oct 20167:00 amRNSInvestor Event
13th Oct 20167:00 amRNSCompletion of NGI composite project
3rd Oct 20167:00 amRNSAcquisition of AAC Cyroma
27th Sep 20161:38 pmRNSResult of AGM
1st Sep 201610:36 amRNSNotice of AGM
3rd Aug 20164:25 pmRNSHolding(s) in Company
2nd Aug 20169:53 amRNSHolding(s) in Company
1st Aug 20168:39 amRNSHolding(s) in Company
28th Jul 20162:01 pmRNSHolding(s) in Company
25th Jul 20167:00 amRNSFully subscribed placing to raise £1.1m
19th Jul 20167:00 amRNSFinal Results
23rd Jun 20167:00 amRNSGraphene Collaboration with CT Engineering
14th Jun 20167:00 amRNSGraphene Collaboration with Absolute Engineering
11th May 20167:00 amRNSGraphene enhanced carbon fibre collaboration
6th Apr 20167:00 amRNSTrading Update
31st Mar 20167:00 amRNS3D Printing with Graphene Trials
11th Mar 20167:00 amRNSResignation of Director
3rd Feb 20167:00 amRNSBoard Changes
11th Dec 20157:00 amRNSDirector Share Purchase
10th Dec 20157:00 amRNSInterim Results
1st Dec 20157:00 amRNSHolding(s) in Company
19th Nov 20157:00 amRNSNotice of Results
4th Nov 20157:00 amRNSChange of Adviser
12th Oct 201511:06 amRNSChange of Registered Office
24th Sep 201511:15 amRNSResult of AGM
21st Sep 20157:00 amRNSVersarien Attending SEC2SV in San Francisco
7th Sep 20157:00 amRNSGrant of US Graphene Patent
19th Aug 20159:53 amRNSAdditional Listing
18th Aug 20152:00 pmRNSPosting of Annual Report
21st Jul 20157:00 amRNSChange of Adviser
21st Jul 20157:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.